- Target
- EGFR
- Reactivity
- Human
- Application
- ELISA
- MW(Calculated)
- --
- MW(Observed)
- --
- Host Species
- Camel
- Isotype
- --
- Conjugate/Modification
- Unmodified
- Modification site
- --
- Recommended Dilution Ratio
- ELISA 1:5000-100000
- Form
- Phosphate-buffered solution
- Source
- Camel, chimeric fusion of Nanobody (VHH) and mouse IgG1 Fc domain , recombinantly produced from 293F cell
- Purification
- Recombinant Expression and Affinity purified
- Purity
- --
- storageCondition
- -15°C to -25°C/1 year(Avoid freeze / thaw cycles)
- Concentration
- Please check the information on the tube
- Clonality
- Monoclonal
- Clone No.
- PN0601
- Immunogen
- Purified recombinant Human EGFR
- Sequence
- --
- Specificity
- This recombinant monoclonal antibody can detects endogenous levels of EGFR protein.
- Gene Name
- EGFR
- Protein Name
- Interleukin-6
- Other Name
- IL6;IFNB2;Interleukin-6;IL-6;B-cell stimulatory factor 2;BSF-2;CTL differentiation factor;CDF;Hybridoma growth factor;Interferon beta-2;IFN-beta-2;IL6 nanobody;
- Organism-1
- Human
- Gene ID-1
- 1956
- SwissProt-1
- P00533
- Organism-2
- --
- Gene ID-2
- --
- SwissProt-2
- --
- Organism-3
- --
- Gene ID-3
- --
- SwissProt-3
- --
- Organism-4
- --
- gene ID-4
- --
- SwissProt-4
- --
- Cellular Localization
- Cell membrane ; Single-pass type I membrane protein . Endoplasmic reticulum membrane ; Single-pass type I membrane protein. Golgi apparatus membrane; Single-pass type I membrane protein. Nucleus membrane; Single-pass type I membrane protein. Endosome . Endosome membrane. Nucleus . In response to EGF, translocated from the cell membrane to the nucleus via Golgi and ER (PubMed:20674546, PubMed:17909029). Endocytosed upon activation by ligand (PubMed:2790960, PubMed:17182860, PubMed:27153536, PubMed:17909029). Colocalized with GPER1 in the nucleus of estrogen agonist-induced cancer-associated fibroblasts (CAF) (PubMed:20551055). .; [Isoform 2]: Secreted.